Pharma Finance and Investment News
Pixel Alchemy/Adobe Stock
Starget Pharma secures $5.1 million investment for targeted cancer therapy
ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy. Read more
5 Nov 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Katy Balls/Getty Images
R&D funding and capital gains: What the budget means for life sciences
This week’s budget saw several major announcements for the UK life sciences sector. Yogan Patel, head of life sciences for MHA, the UK member firm of the global Baker Tilly network, explores what’s been announced and what it means for the industry. Read more
1 Nov 2024
Pharma Manufacturing News + Pharma Finance and Investment News
IM Imagery/Adobe Stock
Recipharm invests in sterile development capabilities
Recipharm is expanding its pharmaceutical development capabilities through targeted investments and the integration of advanced technologies. Read more
4 Oct 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Medix Biochemica
DevCo completes €616 million capital raise for investment in Medix Biochemica
DevCo Partners Ltd has announced a capital raise resulting in 616 MEUR of total commitments for its long-term single asset investment vehicle for Medix Biochemica. Read more
16 Sep 2024
Pharma Manufacturing News + Pharma Finance and Investment News
New Africa / Shutterstock.com
ILC Therapeutics completes £2.5m financing round and bolsters C-suite
ILC Therapeutics, a specialist developer of hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications, has announced that it has successfully completed a fundraise of £2.5m. Read more
11 Sep 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Lightspring / Shutterstock.com
Mestag Therapeutics awarded £1.5m Innovate UK grant to accelerate the Path to Clinic for MST-0300
Mestag Therapeutics has announced that it has been awarded a “Transforming Cancer Therapeutics” grant from Innovate UK’s Cancer Therapeutics program of £1.5 million to accelerate the development of its MST-0300 antibody. Read more
28 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Abselion
Abselion announces £1.1m project to develop next-gen cell platform for viral vector production
Biotechnology companies and research organisations in the UK and Canada are entering into a R&D project jointly funded by a 1.1 million GBP grant from Innovate UK and the National Research Council of Canada Industrial Research Assistance Program. Read more
21 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Oncimmune
Oncimmune Holdings wins $1.5m contract with top 10 pharma company
Oncimmune Holdings, an autoantibody profiling company providing research services to the pharmaceutical and biotechnology industry to enable the delivery of precision medicine, has announced a new contract win with a top 10 global pharma company. Read more
12 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
khunkornStudio / Shutterstock.com
Asceneuron secures $100m funding to advance therapeutics in neurodegenerative diseases
Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, has announced a 100 million USD oversubscribed Series C financing round. Read more
18 Jul 2024
Pharma Manufacturing News + Pharma Finance and Investment News
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
unoL/Shutterstock
PCI and ChiRhoClin partner to prevent shortage of critical orphan pancreatic drug
PCI is collaborating with theranostics specialist ChiRhoClin, Inc. to avoid the potential shortage of a critical diagnostic drug used to test for pancreatic disease and cancer. Read more
20 Nov 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Cytomos
Cytomos secures £5M to scale up production of cell-analysis technology
Cytomos has raised £5 million to scale up production of its first commercial product, Celledonia, built on its cell-analysis technology platform AuraCyt. Read more
19 Nov 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Aleksandr Grechanyuk/Shutterstock
BioPharmaSpec announces three new facilities in Freiburg, Bergamo and Vilnius
BioPharmaSpec has officially announced three new European facilities, focusing on discovery and R&D services. Read more
19 Nov 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Kindeva
Kindeva appoints CIO to lead digital transformation business initiatives
Kindeva Drug Delivery has appointed Prakash Pandian as chief information officer to bolster its executive leadership team and power technological initiatives across the organisation. Read more
18 Nov 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Avantor
Avantor opens Bridgewater facility to tackle life science challenges
Avantor has opened its new flagship Bridgewater Innovation Center, adding to Avantor’s network of 13 research and innovation centres across the globe. Read more
15 Nov 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
World Courier
World Courier welcomes new president and senior vice president
World Courier, a global specialty logistics provider and a part of Cencora, announced the appointment of Laurent Bendavid as the new president and senior vice president of World Courier. Read more
15 Nov 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more